Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Giotopoulos

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Blood|September 14, 2019
Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignanciesDaniel Sasca, Haiyang Yun, George Giotopoulos, et al.
Nature Communications|March 18, 2020
Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AMLSilvia Basilico, Xiaonan Wang, Alison Kennedy, et al.
Blood|February 22, 2018
Glutaminolysis is a metabolic dependency in FLT3<sup>ITD</sup> acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibitionPaolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, et al.
Blood|December 28, 2022
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemiaShuchi Agrawal-Singh, Jaana Bagri, George Giotopoulos, et al.
Science Advances|August 3, 2022
Transcriptional variability accelerates preleukemia by cell diversification and perturbation of protein synthesisShikha Gupta, Oliver M Dovey, Ana Filipa Domingues, et al.
Blood Advances|October 15, 2021
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemiaLiliana Arede, Elena Foerner, Selinde Wind, et al.
The Journal of Experimental Medicine|August 26, 2015
A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progressionGeorge Giotopoulos, Louise van der Weyden, Hikari Osaki, et al.
The Journal of Experimental Medicine|March 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AMLFaisal Basheer, George Giotopoulos, Eshwar Meduri, et al.
Cancer Cell|February 14, 2018
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic ProgenitorsChristopher A G Booth, Nikolaos Barkas, Wen Hao Neo, et al.
Nature Genetics|September 24, 2021
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expressionHaiyang Yun, Nisha Narayan, Shabana Vohra, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Blood|September 14, 2019
Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignanciesDaniel Sasca, Haiyang Yun, George Giotopoulos, et al.
Nature Communications|March 18, 2020
Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AMLSilvia Basilico, Xiaonan Wang, Alison Kennedy, et al.
Blood|February 22, 2018
Glutaminolysis is a metabolic dependency in FLT3<sup>ITD</sup> acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibitionPaolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, et al.
Blood|December 28, 2022
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemiaShuchi Agrawal-Singh, Jaana Bagri, George Giotopoulos, et al.
Science Advances|August 3, 2022
Transcriptional variability accelerates preleukemia by cell diversification and perturbation of protein synthesisShikha Gupta, Oliver M Dovey, Ana Filipa Domingues, et al.
Blood Advances|October 15, 2021
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemiaLiliana Arede, Elena Foerner, Selinde Wind, et al.
The Journal of Experimental Medicine|August 26, 2015
A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progressionGeorge Giotopoulos, Louise van der Weyden, Hikari Osaki, et al.
The Journal of Experimental Medicine|March 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AMLFaisal Basheer, George Giotopoulos, Eshwar Meduri, et al.
Cancer Cell|February 14, 2018
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic ProgenitorsChristopher A G Booth, Nikolaos Barkas, Wen Hao Neo, et al.
Nature Genetics|September 24, 2021
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expressionHaiyang Yun, Nisha Narayan, Shabana Vohra, et al.
Pageof 4